San Francisco - The known teratogenicity of isotretinoin, as well as a possible link to psychiatric illness, means that physicians prescribing the drug must carefully follow risk-management guidelines. These guidelines are mandated by the FDA.
Highlights from AAD 2023
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
New Technology Could Allow Us to Rethink Alopecia Scores
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Pregnant Women with Skin Conditions May Require Dermatologic Intervention
Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
2 Clarke Drive Cranbury, NJ 08512